
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
CluePoints, a provider of RBM and Data Quality Oversight solutions, announces four year partnership with ONO Pharmaceutical. This agreement will see that ONO utilizes CluePoints centralized statistical monitoring platform in order to drive its RBM strategy and position in Japan.
Read the full release






